S. Majjaj

发表

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology

C. Sotiriou, C. Desmedt, D. Larsimont, 2014, BMC Genomics.

Genomic Characterization of Primary Invasive Lobular Breast Cancer.

P. Campbell, C. Sotiriou, F. Bertucci, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression Cloning of an Interferon-inducible 17-kDa Membrane Protein Implicated in the Control of Cell Growth (*)

D. Caput, S. Majjaj, O. Leo, 1995, The Journal of Biological Chemistry.

DNA methylation profiling reveals a predominant immune component in breast cancers

Benjamin Haibe-Kains, Stefan Michiels, Matthieu Defrance, 2011, EMBO molecular medicine.

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays

C. Sotiriou, S. Loi, S. Michiels, 2018, PloS one.

Evaluation of the histological size of the sentinel lymph node metastases using RT–PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer

D. Larsimont, R. Salgado, S. Majjaj, 2010, Breast Cancer Research and Treatment.

Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome

C. Sotiriou, C. Desmedt, D. Larsimont, 2020, EBioMedicine.

Timing evolution of lobular breast cancer through phylogenetic analysis

C. Sotiriou, F. Bertucci, C. Desmedt, 2022, EBioMedicine.

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in breast cancer

T. Speed, C. Sotiriou, S. Loi, 2010 .

Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment

John Quackenbush, C. Sotiriou, S. Loi, 2012, Clinical Cancer Research.

Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution

S. Majjaj, E. Marbaix, J. Dumont, 2017, Oncotarget.

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer

Paul Ellis, Terence P. Speed, Benjamin Haibe-Kains, 2010, Proceedings of the National Academy of Sciences.

Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations

C. Sotiriou, C. Desmedt, M. Piccart, 2018, npj Breast Cancer.

Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial

C. Sotiriou, S. Loi, M. Piccart, 2021, Clinical Cancer Research.

Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer

C. Sotiriou, C. Desmedt, A. Harris, 2011, PloS one.

Biology of breast cancer during pregnancy using genomic profiling.

Diether Lambrechts, Sylvain Brohée, Christine Desmedt, 2014, Endocrine-related cancer.

HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

C. Sotiriou, M. Piccart, J. Baselga, 2017, Clinical Cancer Research.

HER 2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER 2

C. Sotiriou, M. Piccart, G. Frampton, 2017 .

Eighteen months clinical experience with the GeneSearch breast lymph node assay.

D. Larsimont, N. Sirtaine, S. Majjaj, 2009, American journal of surgery.

Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes.

D. Larsimont, S. Majjaj, V. Durbecq, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Uncovering the genomic heterogeneity of multifocal breast cancer

D. Amadori, P. Campbell, C. Sotiriou, 2015, The Journal of pathology.

Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations

C. Sotiriou, C. Desmedt, M. Piccart, 2018, npj Breast Cancer.

Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer

C. Sotiriou, F. Bertucci, C. Desmedt, 2020, Clinical Cancer Research.

Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer.

C. Sotiriou, C. Desmedt, D. Larsimont, 2019, Journal of the National Cancer Institute.

Abstract PD9-07: Role of immunosuppressive JNK pathway in the tumor microenvironment among Triple Negative Breast Cancer subtypes in IBCSG Trial 22-00

C. Sotiriou, S. Loi, M. Regan, 2023, Cancer Research.

Abstract CT135: Uncovering the genomic heterogeneity of multifocal breast cancer

D. Amadori, P. Campbell, C. Sotiriou, 2015 .

Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

C. Sotiriou, M. Piccart, J. Baselga, 2019, Clinical Cancer Research.

Abstract P6-07-14: Mutational and transcriptomic characterization of breast cancer (BC) arising in young patients (pts) and during pregnancy and their associations with long-term outcome

C. Sotiriou, S. Loi, C. Desmedt, 2012 .

Characterization and Clinical Evaluation of CD10 þ Stroma Cells in the Breast Cancer Microenvironment

John Quackenbush, C. Sotiriou, S. Loi, 2012 .